Sylvia Wu

435 total citations
10 papers, 272 citations indexed

About

Sylvia Wu is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Sylvia Wu has authored 10 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Pediatrics, Perinatology and Child Health and 2 papers in Hematology. Recurrent topics in Sylvia Wu's work include Acute Myeloid Leukemia Research (1 paper), T-cell and Retrovirus Studies (1 paper) and Neurological diseases and metabolism (1 paper). Sylvia Wu is often cited by papers focused on Acute Myeloid Leukemia Research (1 paper), T-cell and Retrovirus Studies (1 paper) and Neurological diseases and metabolism (1 paper). Sylvia Wu collaborates with scholars based in United States, Japan and Spain. Sylvia Wu's co-authors include Robert G. Strickley, Peyton Jacob, Lisa Yu, Neal L. Benowitz, Michael G. Mulkerrin, Mark Z. Jacobson, M. Hassanzadeh, Francesca Aweeka, John G. Gambertoglio and Graciela Andreï and has published in prestigious journals such as Analytical Chemistry, Analytical Biochemistry and Journal of the American Society of Nephrology.

In The Last Decade

Sylvia Wu

8 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvia Wu United States 7 72 71 46 46 40 10 272
Bjoern B. Burckhardt Germany 10 51 0.7× 66 0.9× 57 1.2× 26 0.6× 15 0.4× 52 322
Kumiko Morita Japan 13 40 0.6× 39 0.5× 118 2.6× 62 1.3× 81 2.0× 35 558
Jeremy A. Bartlett United States 10 42 0.6× 60 0.8× 46 1.0× 11 0.2× 10 0.3× 17 388
Xinrui Wang China 11 22 0.3× 61 0.9× 21 0.5× 13 0.3× 91 2.3× 50 378
Jisook Kim South Korea 9 20 0.3× 105 1.5× 23 0.5× 23 0.5× 58 1.4× 26 294
A Mignot France 10 27 0.4× 48 0.7× 25 0.5× 16 0.3× 57 1.4× 27 328
Eleni Karatza Greece 10 28 0.4× 84 1.2× 58 1.3× 10 0.2× 16 0.4× 21 282
Machiko Watanabe Japan 11 25 0.3× 77 1.1× 24 0.5× 53 1.2× 18 0.5× 41 299
W Döll United States 11 36 0.5× 39 0.5× 167 3.6× 11 0.2× 27 0.7× 27 377
K. Schwenzer United States 7 46 0.6× 97 1.4× 15 0.3× 18 0.4× 60 1.5× 14 445

Countries citing papers authored by Sylvia Wu

Since Specialization
Citations

This map shows the geographic impact of Sylvia Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Wu more than expected).

Fields of papers citing papers by Sylvia Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Wu. The network helps show where Sylvia Wu may publish in the future.

Co-authorship network of co-authors of Sylvia Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia Wu. A scholar is included among the top collaborators of Sylvia Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia Wu. Sylvia Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wu, Sylvia, et al.. (2022). Drug Induced Obstruction? A Case of Ketamine Induced Uropathy. Journal of the American Society of Nephrology. 33(11S). 904–904.
2.
Wu, Sylvia. (2022). In the Name of Shirāz: The stone mosques of the East African coast reconsidered. postmedieval a journal of medieval cultural studies. 13(3-4). 497–515.
3.
Wu, Sylvia, Hitoshi Suzuki, Rimda Wanchoo, et al.. (2019). Thrombotic microangiopathy in dasatinib-treated patients with chronic myeloid leukemia. 4(1-2). 41–45. 1 indexed citations
4.
Wolfgang, Grushenka H.I., Riri Shibata, Jianying Wang, et al.. (2009). GS-9191 Is a Novel Topical Prodrug of the Nucleotide Analog 9-(2-Phosphonylmethoxyethyl)Guanine with Antiproliferative Activity and Possible Utility in the Treatment of Human Papillomavirus Lesions. Antimicrobial Agents and Chemotherapy. 53(7). 2777–2784. 38 indexed citations
5.
Strickley, Robert G., et al.. (2007). Pediatric Drugs-A Review of Commercially Available Oral Formulations. Journal of Pharmaceutical Sciences. 97(5). 1731–1774. 127 indexed citations
6.
Wu, Sylvia, et al.. (2005). The removal of pyroglutamic acid from monoclonal antibodies without denaturation of the protein chains. Analytical Biochemistry. 342(1). 120–125. 15 indexed citations
7.
Naes, L. G., et al.. (2005). WISE solid hydrogen cryostat design overview. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 5904. 590413–590413. 9 indexed citations
8.
Jacob, Peyton, Sylvia Wu, Lisa Yu, & Neal L. Benowitz. (2000). Simultaneous determination of mecamylamine, nicotine, and cotinine in plasma by gas chromatography-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 23(4). 653–661. 49 indexed citations
9.
Quan, Cynthia, et al.. (1999). Susceptibility of rhDNase I to Glycation in the Dry-Powder State. Analytical Chemistry. 71(20). 4445–4454. 15 indexed citations
10.
Hassanzadeh, M., Francesca Aweeka, Sylvia Wu, Mark Z. Jacobson, & John G. Gambertoglio. (1990). Determination of phosphonoformic acid in human plasma and urine by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 525(1). 133–140. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026